Sei Investments CO Spectrum Pharmaceuticals Inc Transaction History

Sei Investments CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$9.08 - $11.84 $28,738 - $37,473	-3,165 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$16.52 - $24.82 $20,451 - $30,727	-1,238 Reduced 28.12%	3,165 $53,000
Q2 2018 Aug 03, 2018	BUY	$14.31 - $21.75 $50,042 - $76,059	3,497 Added 385.98%	4,403 $93,000
Q1 2018 May 11, 2018	BUY	$16.09 - $23.07 $1,415 - $2,030	88 Added 10.76%	906 $15,000
Q3 2017 Nov 06, 2017	BUY	$8.75 - $14.07 $7,157 - $11,509	818	818 $11,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.